Ultragenyx Pharmaceutical’s (RARE) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Ultragenyx Pharmaceutical is a Sell.
Ultragenyx Pharmaceutical’s (RARE) 20-Day exponential moving average is $16.09, while Ultragenyx Pharmaceutical’s (RARE) share price is $15.57, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 50-Day exponential moving average is $17.38, while Ultragenyx Pharmaceutical’s (RARE) share price is $15.57, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 10-Day exponential moving average is $16.27, while Ultragenyx Pharmaceutical’s (RARE) share price is $15.57, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) 100-Day exponential moving average is $19.96, while Ultragenyx Pharmaceutical’s (RARE) share price is $15.57, making it a Sell.
Ultragenyx Pharmaceutical’s (RARE) stock price is $15.57 and Ultragenyx Pharmaceutical’s (RARE) 50-day simple moving average is $16.24, creating a Sell signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $15.57 and Ultragenyx Pharmaceutical’s (RARE) 100-day simple moving average is $22.33, creating a Sell signal.
Ultragenyx Pharmaceutical’s (RARE) stock price is $15.57 and Ultragenyx Pharmaceutical’s (RARE) 200-day simple moving average is $22.77, creating a Sell signal.